DOCSLIB.ORG

Identification and Evaluation of Antivirals for Rift Valley Fever Virus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identification and Evaluation of Antivirals for Rift Valley Fever Virus Identification and evaluation of antivirals for Rift Valley fever virus by Yuekun Lang B.S., Northeast Agricultural University, 2009 M.S., Northeast Agricultural University, 2012 AN ABSTRACT OF A DISSERTATION submitted in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY Department of Diagnostic Medicine/Pathobiology College of Veterinary Medicine KANSAS STATE UNIVERSITY Manhattan, Kansas 2017 Abstract Rift Valley fever virus (RVFV) is an enveloped, negative-sense, ssRNA virus with a tripartite genome that causes morbidity and mortality in both livestock and humans. Although RVFV is mainly circulating in mainland Africa, this arthropod-borne virus is a potential threat to the other parts of the world. No fully licensed vaccines for human or animal use in the U.S., and effective antiviral drugs have not been identified. As virulent RVFV strains are only handled in biosafety level (BSL) 3 or higher level facilities in the U.S., few laboratories have access to RVFV which limits antiviral development. However, it is crucial to develop effective antivirals to protect public and animal health. Animal models that reproduce Rift Valley fever are vital to identifying and developing antiviral compounds. The currently available attenuated RVFV strain, MP12, provides a BSL-2 challenge model virus for preliminary investigations of RVFV prior to using the virulent RVFV strains. All strains of RVFV have a highly conserved genome, indicating that antivirals or vaccines effective against any RVFV strain will most likely be effective for all RVFV strains. Therefore, we hypothesize that the MP12 is a suitable model virus that can be used for identification and evaluation of effective RVF antivirals. The first objective of this project was to establish a mouse model susceptible to MP12 infection. Based on the literature, we selected and screened six different strains of mice to test their susceptibilities to MP12. We found the STAT-1 knockout mice are the most susceptible to MP12 infection based on clinical symptoms, mortality, viremia, virus replication, histopathological, and immunochemical analyses. Importantly, these mice displayed acute-onset hepatitis and delayed-onset encephalitis similar to severe cases of human RVFV infection. Our second objective was to identify potential antiviral drugs in vitro. We developed and employed a cell-based assay using the recombinant MP12 virus expressing Renilla luciferase to screen a library of 727 small compounds purchased from National Institutes of Health. Of the compounds, 23 were identified and further tested for their inhibitory activities on the recombinant MP12 virus expressing green fluorescent protein. Further plaque reduction assays confirmed that two compounds inhibited replication of parental RVFV MP12 strain with limited cytotoxic effects. The 50% inhibitory concentrations using an MP12 multiplicity of infection (MOI) of 2 were 211.4 µM and 139.5 µM, respectively. Our third objective was to evaluate these two candidates, 6-azauridine and mitoxantrone, in vivo using our mouse model. After one-hour post MP12 infection via an intranasal route, treatment was given intranasally twice daily. Mice treated with placebo and 6-azauridine displayed severe weight loss and reached the threshold for euthanasia with obvious neurological signs, while mice treated with ribavirin (a known antiviral drug) or mitoxantrone showed delayed onset of disease. This result indicates that the mitoxantrone can improve the outcome of RVFV infection in our mouse model. The underlying mechanism of mitoxantrone to inhibit RVFV replication remains to be investigated. Our studies build the foundation for identification and development of antivirals against RVFV in a BSL-2 environment. Identification and evaluation of antivirals for Rift Valley fever virus by Yuekun Lang B.S., Northeast Agricultural University, 2009 M.S., Northeast Agricultural University, 2012 A DISSERTATION submitted in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY Department of Diagnostic Medicine/Pathobiology College of Veterinary Medicine KANSAS STATE UNIVERSITY Manhattan, Kansas 2017 Approved by: Major Professor Wenjun Ma Copyright © Yuekun Lang. Abstract Rift Valley fever virus (RVFV) is an enveloped, negative-sense, ssRNA virus with a tripartite genome that causes morbidity and mortality in both livestock and humans. Although RVFV is mainly circulating in mainland Africa, this arthropod-borne virus is a potential threat to the other parts of the world. No fully licensed vaccines for human or animal use in the U.S., and effective antiviral drugs have not been identified. As virulent RVFV strains are only handled in biosafety level (BSL) 3 or higher level facilities in the U.S., few laboratories have access to RVFV which limits antiviral development. However, it is crucial to develop effective antivirals to protect public and animal health. Animal models that reproduce Rift Valley fever are vital to identifying and developing antiviral compounds. The currently available attenuated RVFV strain, MP12, provides a BSL-2 challenge model virus for preliminary investigations of RVFV prior to using the virulent RVFV strains. All strains of RVFV have a highly conserved genome, indicating that antivirals or vaccines effective against any RVFV strain will most likely be effective for all RVFV strains. Therefore, we hypothesize that the MP12 is a suitable model virus that can be used for identification and evaluation of effective RVF antivirals. The first objective of this project was to establish a mouse model susceptible to MP12 infection. Based on the literature, we selected and screened six different strains of mice to test their susceptibilities to MP12. We found the STAT-1 knockout mice are the most susceptible to MP12 infection based on clinical symptoms, mortality, viremia, virus replication, histopathological, and immunochemical analyses. Importantly, these mice displayed acute-onset hepatitis and delayed-onset encephalitis similar to severe cases of human RVFV infection. Our second objective was to identify potential antiviral drugs in vitro. We developed and employed a cell-based assay using the recombinant MP12 virus expressing Renilla luciferase to screen a library of 727 small compounds purchased from National Institutes of Health. Of the compounds, 23 were identified and further tested for their inhibitory activities on the recombinant MP12 virus expressing green fluorescent protein. Further plaque reduction assays confirmed that two compounds inhibited replication of parental RVFV MP12 strain with limited cytotoxic effects. The 50% inhibitory concentrations using an MP12 multiplicity of infection (MOI) of 2 were 211.4 µM and 139.5 µM, respectively. Our third objective was to evaluate these two candidates, 6-azauridine and mitoxantrone, in vivo using our mouse model. After one-hour post MP12 infection via an intranasal route, treatment was given intranasally twice daily. Mice treated with placebo and 6-azauridine displayed severe weight loss and reached the threshold for euthanasia with obvious neurological signs, while mice treated with ribavirin (a known antiviral drug) or mitoxantrone showed delayed onset of disease. This result indicates that the mitoxantrone can improve the outcome of RVFV infection in our mouse model. The underlying mechanism of mitoxantrone to inhibit RVFV replication remains to be investigated. Our studies build the foundation for identification and development of antivirals against RVFV in a BSL-2 environment. Table of Contents List of Figures ................................................................................................................................ xi List of Tables ................................................................................................................................ xii Acknowledgements ...................................................................................................................... xiii Chapter 1 - General Introduction .................................................................................................... 1 1.1 Rift Valley fever ................................................................................................................... 1 1.1.1 History and distribution of RVF .................................................................................... 1 1.1.2 Classification .................................................................................................................. 4 1.1.3 Transmission .................................................................................................................. 4 1.1.4 RVFV lifecycle .............................................................................................................. 7 1.1.5 Morphology .................................................................................................................. 11 1.1.6 Genome ........................................................................................................................ 13 1.1.7 Functions of RVFV proteins ........................................................................................ 13 L protein ............................................................................................................................ 13 N protein ........................................................................................................................... 13 Glycoproteins Gn and Gc .................................................................................................
Load more

Recommended publications
  • Emergence of Toscana Virus, Romania, 2017–2018 Corneliu P
    DISPATCHES Emergence of Toscana Virus, Romania, 2017–2018 Corneliu P. Popescu,1 Ani I. Cotar,1 Sorin Dinu, Mihaela Zaharia, Gratiela Tardei, Emanoil Ceausu, Daniela Badescu, Simona Ruta, Cornelia S. Ceianu, Simin A. Florescu We describe a series of severe neuroinvasive infections tertiary-care facility (Dr. Victor Babes Clinical Hospi- caused by Toscana virus, identifi ed by real-time reverse tal of Infectious Diseases, Bucharest, Romania). transcription PCR testing, in 8 hospitalized patients in Bu- charest, Romania, during the summer seasons of 2017 The Study and 2018. Of 8 patients, 5 died. Sequencing showed that We tested 31 adult patients (18 in 2017 and 13 in 2018) the circulating virus belonged to lineage A. with neurologic manifestations; all tested negative by cerebrospinal fl uid nucleic acid testing for WNV, her- oscana phlebovirus (TOSV; genus Phlebovirus, pesviruses, and enteroviruses. Seven confi rmed cases Tfamily Phenuiviridae) is transmitted by sand and 1 probable case of TOSV neuroinvasive disease fl ies. Three genetic lineages (A, B, and C) with dif- were identifi ed by real-time reverse transcription ferent geographic distribution have been described PCR (rRT-PCR); cycle threshold values ranged from to date. TOSV is the only sand fl y–transmitted vi- 34.61 to 41.18. rus causing neuroinvasive disease in humans and All cases were characterized by progression to the most prevalent arthropodborne virus in the severe illness (encephalitis in 7 cases and meningo- Mediterranean area; however, it remains a neglect- encephalitis in 1 case). Cerebrospinal fl uid (CSF) was ed pathogen and is seldom included in the diag- analyzed after lumbar puncture in all patients.
    [Show full text]
  • Experimental Infection of Dogs with Toscana Virus and Sandfly
    microorganisms Article Experimental Infection of Dogs with Toscana Virus and Sandfly Fever Sicilian Virus to Determine Their Potential as Possible Vertebrate Hosts Clara Muñoz 1, Nazli Ayhan 2,3 , Maria Ortuño 1, Juana Ortiz 1, Ernest A. Gould 2, Carla Maia 4, Eduardo Berriatua 1 and Remi N. Charrel 2,* 1 Departamento de Sanidad Animal, Facultad de Veterinaria, Campus de Excelencia Internacional Regional “Campus Mare Nostrum”, Universidad de Murcia, 30100 Murcia, Spain; [email protected] (C.M.); [email protected] (M.O.); [email protected] (J.O.); [email protected] (E.B.) 2 Unite des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM U1207, IHU Mediterranee Infection), 13005 Marseille, France; [email protected] (N.A.); [email protected] (E.A.G.) 3 EA7310, Laboratoire de Virologie, Université de Corse-Inserm, 20250 Corte, France 4 Global Health and Tropical Medicine, GHMT, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Rua da Junqueira, 100, 1349-008 Lisboa, Portugal; [email protected] * Correspondence: [email protected] Received: 2 April 2020; Accepted: 19 April 2020; Published: 20 April 2020 Abstract: The sandfly-borne Toscana phlebovirus (TOSV), a close relative of the sandfly fever Sicilian phlebovirus (SFSV), is one of the most common causes of acute meningitis or meningoencephalitis in humans in the Mediterranean Basin. However, most of human phlebovirus infections in endemic areas either are asymptomatic or cause mild influenza-like illness. To date, a vertebrate reservoir for sandfly-borne phleboviruses has not been identified. Dogs are a prime target for blood-feeding phlebotomines and are the primary reservoir of human sandfly-borne Leishmania infantum.
    [Show full text]
  • A Look Into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins
    viruses Review A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins Shanna S. Leventhal, Drew Wilson, Heinz Feldmann and David W. Hawman * Laboratory of Virology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA; [email protected] (S.S.L.); [email protected] (D.W.); [email protected] (H.F.) * Correspondence: [email protected]; Tel.: +1-406-802-6120 Abstract: In 2016, the Bunyavirales order was established by the International Committee on Taxon- omy of Viruses (ICTV) to incorporate the increasing number of related viruses across 13 viral families. While diverse, four of the families (Peribunyaviridae, Nairoviridae, Hantaviridae, and Phenuiviridae) contain known human pathogens and share a similar tri-segmented, negative-sense RNA genomic organization. In addition to the nucleoprotein and envelope glycoproteins encoded by the small and medium segments, respectively, many of the viruses in these families also encode for non-structural (NS) NSs and NSm proteins. The NSs of Phenuiviridae is the most extensively studied as a host interferon antagonist, functioning through a variety of mechanisms seen throughout the other three families. In addition, functions impacting cellular apoptosis, chromatin organization, and transcrip- tional activities, to name a few, are possessed by NSs across the families. Peribunyaviridae, Nairoviridae, and Phenuiviridae also encode an NSm, although less extensively studied than NSs, that has roles in antagonizing immune responses, promoting viral assembly and infectivity, and even maintenance of infection in host mosquito vectors. Overall, the similar and divergent roles of NS proteins of these Citation: Leventhal, S.S.; Wilson, D.; human pathogenic Bunyavirales are of particular interest in understanding disease progression, viral Feldmann, H.; Hawman, D.W.
    [Show full text]
  • Ÿþs a L E H a E I F a N P H D T H E S
    FUNCTIONAL ANALYSIS OF THE ORTHOBUNYAVIRUS NUCLEOCAPSID (N) PROTEIN Saleh A. Eifan A Thesis Submitted for the Degree of PhD at the University of St. Andrews 2008 Full metadata for this item is available in the St Andrews Digital Research Repository at: https://research-repository.st-andrews.ac.uk/ Please use this identifier to cite or link to this item: http://hdl.handle.net/10023/542 This item is protected by original copyright This item is licensed under a Creative Commons License Functional analysis of the orthobunyavirus nucleocapsid (N) protein Saleh A. Eifan Centre for Biomolecular Sciences University of St.Andrews A thesis submitted for the degree of Doctor of Philosophy in Molecular Virology April 2008 Summary Summary Bunyamwera virus (BUNV) is the prototype of the family Bunyaviridae. It has a tripartite genome consisting of negative sense RNA segments called large (L), medium (M) and small (S). The S segment encodes the nucleocapsid protein (N) of 233 amino acids. The N protein encapsidates all three segments to form transcriptionally active ribonucleoproteins (RNPs). The aim of this project was to determine the domain map of BUNV N protein. To investigate residues in BUNV N crucial for its functionality, random and site- specific mutagenesis were performed on a cDNA clone encoding the BUNV N protein. In total, 102 single amino acid substitutions were generated in the BUNV N protein sequence. All mutant N proteins were used in a BUNV minigenome system to compare their activity to wt BUNV N. The mutant proteins displayed a wide-range of activity, from parental-like to essentially inactive.
    [Show full text]
  • Rapid Identification of Toscana Virus by Nested PCR During an Outbreak
    JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1996, p. 2500–2502 Vol. 34, No. 10 0095-1137/96/$04.0010 Copyright q 1996, American Society for Microbiology Rapid Identification of Toscana Virus by Nested PCR during an Outbreak in the Siena Area of Italy MARCELLO VALASSINA,* MARIA GRAZIA CUSI, AND PIER EGISTO VALENSIN Department of Molecular Biology, Section of Microbiology, University of Siena, 53100 Siena, Italy Received 26 March 1996/Returned for modification 22 July 1996/Accepted 24 July 1996 The sand fly-transmitted Toscana virus is recognized as an etiologic agent of an aseptic meningitis with a long convalescence. This infection has been reported overall in many tourists or in a seronegative population circulating in endemic Mediterranean areas (Italy, Portugal, Egypt, and Cyprus). We report a cluster of acute Toscana virus infections in the local population during the summer of 1995. Twenty-one clinical cases of meningitis were investigated for the presence of Toscana virus by nested PCR performed on the S segment of the virus RNA extracted from cerebrospinal fluid samples. Sandfly fever viruses are transmitted in endemic areas by the virus was harvested at the appearance of a lytic cytopathic effect on cell culture, sandfly (Phlebotomus spp.) and can cause headache, myalgia, which was confirmed by hemadsorption with goose erythrocytes. The negative cell cultures were maintained for 14 days after the supernatant was harvested and ocular symptoms, and fever. These viruses belong to the Bun- blind passaged on cells. yaviridae family, genus Phlebovirus. The enveloped virions have Serological test. An IFA was performed to detect anti-TOS virus immuno- a segmented RNA genome consisting of three noncovalently globulin M (IgM) and IgG according to a procedure described elsewhere (24).
    [Show full text]
  • TITLE PAGE Phylodynamic Analysis of the Historical
    bioRxiv preprint doi: https://doi.org/10.1101/380477; this version posted July 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Phylodynamic analysis of Toscana virus TITLE PAGE Phylodynamic analysis of the historical spread of Toscana virus around the Mediterranean M. Grazia Cusi1, Claudia Gandolfo1, Gianni Gori Savellini1, Chiara Terrosi1, Rebecca A. Sadler2 & Derek Gatherer2* (surnames underlined) 1 Section of Microbiology, Department of Medical Biotechnologies, Siena University School of Medicine, Siena, Italy 2 Division of Biomedical & Life Sciences, Faculty of Health & Medicine, Lancaster University, LA1 3SA, UK. * Corresponding author: [email protected] +44 1524 592900 Other author emails: [email protected] [email protected] [email protected] [email protected] [email protected] Word count: 4922 Running Title: Phylodynamic analysis of Toscana virus 1 bioRxiv preprint doi: https://doi.org/10.1101/380477; this version posted July 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Phylodynamic analysis of Toscana virus Phylodynamic analysis of the historical spread of Toscana virus around the Mediterranean M. Grazia Cusi1, Claudia Gandolfo1, Gianni Gori Savellini1, Chiara Terrosi1, Rebecca A. Sadler2 & Derek Gatherer2* (surnames underlined) 1 Section of Microbiology, Department of Medical Biotechnologies, Siena University School of Medicine, Siena, Italy 2 Division of Biomedical & Life Sciences, Faculty of Health & Medicine, Lancaster University, LA1 3SA, UK.
    [Show full text]
  • Diversity and Evolutionary Origin of the Virus Family Bunyaviridae
    Diversity and Evolutionary Origin of the Virus Family Bunyaviridae Dissertation zur Erlangung des Doktorgrades (Dr. rer. nat.) der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn vorgelegt von Marco Marklewitz aus Hannover Bonn, 2016 Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn 1. Gutachter: Prof. Dr. Christian Drosten 2. Gutachter: Prof. Dr. Bernhard Misof Tag der Promotion: 21.12.2016 Erscheinungsjahr: 2017 Danksagung Zu Beginn möchte ich mich ganz herzlich bei meinem Doktorvater Prof. Christian Drosten bedanken, dass er mir ermöglicht hat, an einem solch vielfältigen und spannenden Thema zu arbeiten. Für Fragen hatte er jederzeit ein offenes Ohr und bei auftretenden Problemen war er immer sehr hilfsbereit. Des Weiteren möchte ich mich herzlich bei meiner Prüfungskommission, bestehend aus meinem 2. Gutachter Prof. Bernhard Misof sowie Prof. Clemens Simmer und PD Dr. Lars Podsiadlowski, für ihre Zeit und Bereitschaft danken mich zu prüfen. Mein ganz besonder Dank geht an PD Dr. Sandra Junglen für ihre hervorragende und kompetente Betreuung während der Jahre meiner Doktorarbeit. Ich habe es als eine Ehre empfunden, ein Teil ihrer zu Beginn noch sehr jungen Arbeitsgruppe zu sein, danke ihr sehr für ihr Vertrauen und hoffe, sie mit meiner (zukünftigen) Arbeit stolz zu machen. Die Atmosphäre in ihrer Arbeitsgruppe ist immer sehr positiv und ermöglicht, die Arbeit mit viel Spaß zu verbinden. Insbesondere möchte ich herausstellen, dass ich ihr für die Möglichkeit besonders dankbar bin, neben meiner Doktorarbeit Feldarbeiten in Panama durchzuführen. Diese Zeit hat mein Leben auf die positivste Art und Weise nachhaltig beeinflusst. Mein großer Dank gilt auch allen Kolleginnen und Kollegen in den Virologie-Laboratorien der Augenklinik für ihre ständige Hilfs- und Diskussionsbereitschaft, ihr Zuhören bei Problemen sowie für ihre Freundschaft über all die Jahre.
    [Show full text]
  • Discovery and Characterisation of a New Insect-Specific Bunyavirus from Culex Mosquitoes Captured in Northern Australia
    Virology 489 (2016) 269–281 Contents lists available at ScienceDirect Virology journal homepage: www.elsevier.com/locate/yviro Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia$ Jody Hobson-Peters a,n,1, David Warrilow b,1, Breeanna J McLean a, Daniel Watterson a, Agathe M.G. Colmant a, Andrew F. van den Hurk b, Sonja Hall-Mendelin b, Marcus L. Hastie c, Jeffrey J. Gorman c, Jessica J. Harrison a, Natalie A. Prow a,2, Ross T. Barnard a, Richard Allcock d,e, Cheryl A. Johansen a,3, Roy A. Hall a,nn a Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia 4072, Queensland, Australia b Public Health Virology Forensic and Scientific Services, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland 4108, Australia c Protein Discovery Centre, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD 4006, Australia d Lottery West State Biomedical Facility – Genomics, School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Western Australia, Australia e Department of Clinical Immunology, Pathwest Laboratory Medicine Western Australia, Royal Perth Hospital, Perth, Western Australia, Australia article info abstract Article history: Insect-specific viruses belonging to significant arboviral families have recently been discovered. These Received 4 September 2015 viruses appear to be maintained within the insect population without the requirement for replication in a Returned to author for revisions vertebrate host. Mosquitoes collected from Badu Island in the Torres Strait in 2003 were analysed for 21 September 2015 insect-specific viruses.
    [Show full text]
  • Experimental Infection of Dogs with Toscana Virus and Sandfly Fever Sicilian Virus to Determine Their Potential As Possible Vertebrate Hosts
    microorganisms Article Experimental Infection of Dogs with Toscana Virus and Sandfly Fever Sicilian Virus to Determine Their Potential as Possible Vertebrate Hosts Clara Muñoz 1, Nazli Ayhan 2,3 , Maria Ortuño 1, Juana Ortiz 1, Ernest A. Gould 2, Carla Maia 4, Eduardo Berriatua 1 and Remi N. Charrel 2,* 1 Departamento de Sanidad Animal, Facultad de Veterinaria, Campus de Excelencia Internacional Regional “Campus Mare Nostrum”, Universidad de Murcia, 30100 Murcia, Spain; [email protected] (C.M.); [email protected] (M.O.); [email protected] (J.O.); [email protected] (E.B.) 2 Unite des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM U1207, IHU Mediterranee Infection), 13005 Marseille, France; [email protected] (N.A.); [email protected] (E.A.G.) 3 EA7310, Laboratoire de Virologie, Université de Corse-Inserm, 20250 Corte, France 4 Global Health and Tropical Medicine, GHMT, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Rua da Junqueira, 100, 1349-008 Lisboa, Portugal; [email protected] * Correspondence: [email protected] Received: 2 April 2020; Accepted: 19 April 2020; Published: 20 April 2020 Abstract: The sandfly-borne Toscana phlebovirus (TOSV), a close relative of the sandfly fever Sicilian phlebovirus (SFSV), is one of the most common causes of acute meningitis or meningoencephalitis in humans in the Mediterranean Basin. However, most of human phlebovirus infections in endemic areas either are asymptomatic or cause mild influenza-like illness. To date, a vertebrate reservoir for sandfly-borne phleboviruses has not been identified. Dogs are a prime target for blood-feeding phlebotomines and are the primary reservoir of human sandfly-borne Leishmania infantum.
    [Show full text]
  • Virus De La Dengue, Flavivirus  Virus Zika, Flavivirus
    Actualités sur les émergences virales 2012‐2014 Les arboviroses : Pr Rémi CHARREL, Université d’Aix Marseille ‐ Institut de Recherche pour le Développement , Marseille, France IHU Méditerranée Infection, Marseille, France ACNBH 43ème Colloque National des Biologistes des Hôpitaux Marseille, 5‐7 novembre 2014 ODPC N°1495 DECLARATION D’INTERET DANS LE CADRE DE MISSIONS DE FORMATION REALISEES POUR L’ACNBH Pr. Rémi CHARREL Exerçant au CHU APHM Timone et IHU Méditerranée –Infection déclare sur l’honneur ne pas avoir d'intérêt, direct ou indirect (financier) avec les entreprises pharmaceutiques, du diagnostic ou d’édition de logiciels susceptible de modifier mon jugement ou mes propos, concernant le DMDIV et/ou le sujet présenté. Modalités de la recherche bibliographique dans le journal Eurosurveillance, édité par le ECDC o Gratuit o hebdomadaire o Open Access o www.eurosurveillance.org/ o dans PubMED 2012‐2014: www.ncbi.nlm.nih.gov/pubmed/ dans ProMED: www.promedmail.org/ Les virus dont nous allons parler: les arbovirus ARthropod‐BOrne virus transmis par les moustiques du genre Culex virus West Nile, flavivirus Virus Usutu, flavivirus transmis par les moustiques du genre Aedes virus de la dengue, flavivirus virus Zika, flavivirus virus Chikungunya, alphavirus Les virus dont nous allons parler: les arbovirus ARthropod‐BOrne virus transmis par les phlébotomes virus Toscana, Phlebovirus, Bunyaviridae Les virus dont nous allons parler: les virus non vectorisés transmis par contact avec le sang et fluides biologiques virus Ebola, filovirus
    [Show full text]
  • Update in Diagnostics of Toscana Virus Infection in a Hyperendemic Region (Southern Spain)
    viruses Article Update in Diagnostics of Toscana Virus Infection in a Hyperendemic Region (Southern Spain) Sara Sanbonmatsu-Gámez 1,2,3 , Irene Pedrosa-Corral 1,2 , José María Navarro-Marí 1,2,3 and Mercedes Pérez-Ruiz 2,3,4,* 1 Laboratorio de Referencia de Virus de Andalucía, Servicio de Microbiología, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain; [email protected] (S.S.-G.); [email protected] (I.P.-C.); [email protected] (J.M.N.-M.) 2 Instituto de Investigación Biosanitaria ibs.Granada, 18012 Granada, Spain 3 Red de Investigación Cooperativa en Enfermedades Tropicales (RICET), 28029 Madrid, Spain 4 Servicio de Microbiología, Hospital Regional Universitario de Málaga, 29010 Málaga, Spain * Correspondence: [email protected] Abstract: The sandfly fever Toscana virus (TOSV, genus Phlebovirus, family Phenuiviridae) is endemic in Mediterranean countries. In Spain, phylogenetic studies of TOSV strains demonstrated that a genotype, different from the Italian, was circulating. This update reports 107 cases of TOSV neurological infection detected in Andalusia from 1988 to 2020, by viral culture, serology and/or RT-PCR. Most cases were located in Granada province, a hyperendemic region. TOSV neurological infection may be underdiagnosed since few laboratories include this virus in their portfolio. This work presents a reliable automated method, validated for the detection of the main viruses involved in acute meningitis and encephalitis, including the arboviruses TOSV and West Nile virus. This assay solves the need for multiple molecular platforms for different viruses and thus, improves the time to results for these syndromes, which require a rapid and efficient diagnostic approach.
    [Show full text]
  • Shi, X., and Elliott, RM (2009)
    Shi, X., and Elliott, R.M. (2009) Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins. Journal of General Virology, 90 (2). pp. 297-306. ISSN 0022-1317 Copyright © 2009 SGM A copy can be downloaded for personal non-commercial research or study, without prior permission or charge Content must not be changed in any way or reproduced in any format or medium without the formal permission of the copyright holder(s) When referring to this work, full bibliographic details must be given http://eprints.gla.ac.uk/80069 Deposited on: 21 May 2013 Enlighten – Research publications by members of the University of Glasgow http://eprints.gla.ac.uk Journal of General Virology (2009), 90, 297–306 DOI 10.1099/vir.0.007567-0 Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins Xiaohong Shi and Richard M. Elliott Correspondence Centre for Biomolecular Sciences, School of Biology, University of St Andrews, North Haugh, St Richard M. Elliott Andrews, Scotland KY16 9ST, UK [email protected] The L protein of Bunyamwera virus (BUNV; family Bunyaviridae) is an RNA-dependent RNA polymerase, 2238 aa in length, that catalyses transcription and replication of the negative-sense, tripartite RNA genome. To learn more about the molecular interactions of the L protein and to monitor its intracellular distribution we inserted a 14 aa V5 epitope derived from parainfluenza virus type 5, against which high-affinity antibodies are available, into different regions of the protein. Insertion of the epitope at positions 1935 or 2046 resulted in recombinant L proteins that retained functionality in a minireplicon assay.
    [Show full text]